Ovarian cancer

You have access
Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCl(NH₃)₂μ {trans-Pt(3-hydroxypyridine)₂H₂N(CH₂)₅NH₂)₂}] Cl₄ in Human Ovarian Cancer Cells
SHAHNAZ A. HAMAD, PHILIP BEALE, JUN QING YU and FAZLUL HUQ

Anticancer Research April 2014, 34 (4) 1923-1929;
You have access
Biomarkers for Predicting Complete Debulking in Ovarian Cancer: Lessons to Be Learned
CARSTEN LINDBERG FAGÖ-OLSEN, BENT OTTESEN, IB JARLE CHRISTENSEN, ESTRID HØGDALL, LENE LUNDVALL, LOTTE NEDERGAARD, SVEND-AAGE ENGELHOLM, SOFIE LEISBY ANTONSEN, MAGNUS LYDOLPH and CLAUS HØGDALL

Anticancer Research February 2014, 34 (2) 679-682;
You have access
Activation of YAP1 Is Associated with Poor Prognosis and Response to Taxanes in Ovarian Cancer
WOOJIN JEONG, SANG-BAE KIM, BO HWA SOHN, YUN-YONG PARK, EUN SUNG PARK, SANG CHEOL KIM, SUNG SOO KIM, RANDY L. JOHNSON, MICHAEL BIRRER, DAVID S. L. BOWTELL, GORDON B. MILLS, ANIL SOOD and JU-SEOG LEE

Anticancer Research February 2014, 34 (2) 811-817;
You have access
‘BRCAness’ and Its Implications for Platinum Action in Gynecologic Cancer
FRANCO MUGGIA and TAMAR SAFRA

Anticancer Research February 2014, 34 (2) 551-556;
You have access
The Role of Inhibitor of DNA-binding 1 (ID-1) Protein and Angiogenesis in Serous Ovarian Cancer
MILAN-PAUL KUBELAC, BOGDAN FETICA, IOAN-CĂTĂLIN VLAD, ANNAMARIA FULOP, ANCA POPA and PATRICIU ACHIMAŞ-CADARIU

Anticancer Research January 2014, 34 (1) 413-416;
You have access
Comparison of Minichromosome Maintenance Proteins (MCM-3, MCM-7) and Metallothioneins (MT-I/II, MT-III) Expression in Relation to Clinicopathological Data in Ovarian Cancer
CHRISTOPHER KOBIERZYCKI, BARTOSZ PULA, MATEUSZ SKIBA, KAROLINA JABLONSKA, KRZYSZTOF LATKOWSKI, MACIEJ ZABEL, EWA NOWAK-MARKWITZ, MAREK SPACZYNSKI, WITOLD KEDZIA, MARZENA PODHORSKA-OKOLOW and PIOTR DZIEGIEL

Anticancer Research December 2013, 33 (12) 5375-5383;
You have access
MCP-1 Promotes Invasion and Adhesion of Human Ovarian Cancer Cells
SHIGENORI FURUKAWA, SHU SOEDA, YUICHIRO KIKO, OSAMU SUZUKI, YUKO HASHIMOTO, TAKAFUMI WATANABE, HIROSHI NISHIYAMA, KAZUHIRO TASAKI, HIROSHI HOJO, MASAFUMI ABE and KEIYA FUJIMORI

Anticancer Research November 2013, 33 (11) 4785-4790;
You have access
Prevention of Carboplatin-induced Resistance in Human Ovarian Tumor Xenografts by Selenite
PAULA B. CAFFREY and GERALD D. FRENKEL

Anticancer Research October 2013, 33 (10) 4249-4254;
You have access
Anti-proliferative and Pro-apoptotic Effects from Sequenced Combinations of Andrographolide and Cisplatin on Ovarian Cancer Cell Lines
NURHANAN M. YUNOS, SITI S.M. MUTALIP, MUHAMMAD H. JAURI, JUN Q. YU and FAZLUL HUQ

Anticancer Research October 2013, 33 (10) 4365-4371;
You have access
Immunological Response after WT1 mRNA-loaded Dendritic Cell Immunotherapy in Ovarian Carcinoma and Carcinosarcoma
AN COOSEMANS, ANKE VANDERSTRAETEN, SANDRA TUYAERTS, TINA VERSCHUERE, PHILIPPE MOERMAN, ZWI BERNEMAN, IGNACE VERGOTE, FRÉDÉRIC AMANT and STEFAAN W. VAN GOOL

Anticancer Research September 2013, 33 (9) 3855-3859;

Main menu

User menu

Search

Ovarian cancer

Pages